Atossa Therapeutics, Inc.
Clinical trials sponsored by Atossa Therapeutics, Inc., explained in plain language.
Clinical-stage biopharmaceutical company developing therapies for breast cancer and other conditions.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill combo shows promise in halting Hormone-Fueled breast tumors Results expected Nov 2026 (estimated)